FDA DEVICE FACTS
Valiant Navion Thoracic Stent Graft System
Medtronic Vascular
Verified FDA Record identity for medical-device development research. This overview uses only fields stated in the FDA Record and is not a Device Description.医療機器開発の調査用に、確認済みの FDA Record の識別情報を示しています。この概要は FDA Record に記載された項目だけによるもので、機器説明ではありません。
Indications for use
The Valiant Navion™ Thoracic Stent Graft System is indicated for the endovascular repair of all lesions of the descending thoracic aorta (DTA) in patients having the appropriate anatomy including:
• iliac or femoral artery access vessel morphology that is compatible with vascular access techniques, devices, or accessories;
• nonaneurysmal aortic diameter in the range of: o 16 mm to 42 mm for fusiform and saccular aneurysms/penetrating ulcers o 16 mm to 44 mm for blunt traumatic aortic injuries o 19 mm to 45 mm for dissections;
• proximal landing zone (nonaneurysmal aortic proximal neck length for fusiform and saccular aneurysms/penetrating ulcers or nondissected length of aorta proximal to the primary tear for blunt traumatic aortic injuries and dissections) of: o ≥ 20mm for FreeFlo configuration o ≥ 25mm for CoveredSeal configuration; and
• nonaneurysmal aortic distal neck length ≥ 20mm for FreeFlo and CoveredSeal configurations for fusiform and saccular aneurysms/penetrating ulcers.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。